Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The government funding banner was removed from the page; all study details and locations remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-13T22:34:12.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The screenshots show only minor visual/layout adjustments; no substantive changes to the study record, including eligibility criteria, endpoints, or location listings. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T13:05:38.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    Core page content updated with a government funding status notice and explicit open status of the NIH Clinical Center; version updated from v3.0.2 to v3.2.0.
    Difference
    1%
    Check dated 2025-10-02T01:23:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-30T14:27:19.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Updated from Revision: v3.0.1 to v3.0.2; removed 'Back to Top'. This is a minor version update with no substantive changes to core content or pricing/availability.
    Difference
    0.1%
    Check dated 2025-09-16T05:32:20.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-09T01:05:15.000Z thumbnail image

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.